K1115 B1
* Please be kindly noted products are not for therapeutic use. We do not sell to patients.
| Category | Enzyme inhibitors |
| Catalog number | BBF-03601 |
| CAS | |
| Molecular Weight | 416.42 |
| Molecular Formula | C22H24O8 |
Online Inquiry
Capabilities & Facilities
Fermentation Lab
4 R&D and scale-up labs
2 Preparative purification labs
Fermentation Plant
Semi pilot, pilot and industrial plant 4 Manufacturing sites 7 Production lines at pilot scale 100+ Reactors of 30-4000 L; 170+ reactors of 20 KL-30 KL; 24+ reactors of >100 KL 2 Hydrogenation reactors (200 L, 4Mpa and 1000L, 4Mpa)
Product Description
It is a co-produced compound of K-1115A produced by the strain of Streptomyces griseorubiginosus Mer-K1115. K1115 B1 inhibited the direct binding of activator protein-1 (AP-1) to AP-1 oligonucleotide, and the production of collagenase in IL-1 alpha-stimulated rat synovial cells.
- Specification
- Properties
- Reference Reading
- Price Product List
| Synonyms | XR-573 |
| IUPAC Name | 10-hydroxy-8-[5-hydroxy-4-(hydroxymethyl)-1,3-dioxan-2-yl]-3-methyl-1-propyl-1H-benzo[g]isochromene-6,9-dione |
| Canonical SMILES | CCCC1C2=C(C3=C(C=C2C=C(O1)C)C(=O)C=C(C3=O)C4OCC(C(O4)CO)O)O |
| InChI | InChI=1S/C22H24O8/c1-3-4-16-18-11(5-10(2)29-16)6-12-14(24)7-13(20(26)19(12)21(18)27)22-28-9-15(25)17(8-23)30-22/h5-7,15-17,22-23,25,27H,3-4,8-9H2,1-2H3 |
| InChI Key | DRXHQLTVRTWTGH-UHFFFAOYSA-N |
| Appearance | Red Powder |
| Boiling Point | 676.1±55.0°C at 760 mmHg |
| Melting Point | 94-97°C |
| Density | 1.4±0.1 g/cm3 |
| BBF-03816 | Milbemycin oxime | Inquiry |
| BBF-03963 | Pristinamycin | Inquiry |
| BBF-04727 | Strigolactone GR24 | Inquiry |
| BBF-05886 | Notoginsenoside R1 | Inquiry |
| BBF-01210 | Emericid | Inquiry |
| BBF-03428 | Tubermycin B | Inquiry |
Bio Calculators
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
